Follow
Niels Sijbrandi
Niels Sijbrandi
Unknown affiliation
Verified email at alumnus.utwente.nl
Title
Cited by
Cited by
Year
Synthesis, morphology, and properties of segmented poly (ether amide) s with uniform oxalamide-based hard segments
NJ Sijbrandi, AJ Kimenai, EPC Mes, R Broos, G Bar, M Rosenthal, ...
Macromolecules 45 (9), 3948-3961, 2012
632012
A Novel Platinum (II)–Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F–Conjugated Trastuzumab
NJ Sijbrandi, E Merkul, JA Muns, DCJ Waalboer, K Adamzek, M Bolijn, ...
Cancer research 77 (2), 257-267, 2017
372017
Synthesis, morphology and properties of segmented poly (ether ester amide) s comprising uniform glycine or β-alanine extended bisoxalamide hard segments
NJ Sijbrandi, AJ Kimenai, EPC Mes, R Broos, G Bar, M Rosenthal, ...
Polymer 53 (19), 4033-4044, 2012
302012
Platinum (II) as Bifunctional Linker in Antibody–Drug Conjugate Formation: Coupling of a 4‐Nitrobenzo‐2‐oxa‐1, 3‐diazole Fluorophore to Trastuzumab as a Model
DCJ Waalboer, JA Muns, NJ Sijbrandi, RBM Schasfoort, R Haselberg, ...
ChemMedChem 10 (5), 797-803, 2015
272015
Reversibly core-crosslinked PEG-P (HPMA) micelles: Platinum coordination chemistry for competitive-ligand-regulated drug delivery
S Buwalda, B Nottelet, A Bethry, RJ Kok, N Sijbrandi, J Coudane
Journal of colloid and interface science 535, 505-515, 2019
262019
Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys
H Shi, WN Leonhard, NJ Sijbrandi, MJ van Steenbergen, MHAM Fens, ...
Journal of Controlled Release 293, 113-125, 2019
232019
The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor
F Van Dijk, N Teekamp, E Post, D Schuppan, YO Kim, J Zuidema, ...
Journal of Controlled Release 296, 250-257, 2019
202019
Structure formation and hydrogen bonding in all-aliphatic segmented copolymers with uniform hard segments
YI Odarchenko, NJ Sijbrandi, M Rosenthal, AJ Kimenai, EPC Mes, ...
Acta biomaterialia 9 (4), 6143-6149, 2013
202013
In vivo characterization of platinum (II)-based linker technology for the development of antibody–drug conjugates: taking advantage of dual labeling with 195mPt and 89Zr
JA Muns, V Montserrat, HJ Houthoff, K Codée-Van Der Schilden, ...
Journal of Nuclear Medicine 59 (7), 1146-1151, 2018
192018
First platinum (II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs)
E Merkul, NJ Sijbrandi, JA Muns, I Aydin, K Adamzek, HJ Houthoff, ...
Expert Opinion on Drug Delivery 16 (8), 783-793, 2019
172019
An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
E Merkul, JA Muns, NJ Sijbrandi, HJ Houthoff, B Nijmeijer, ...
Angewandte Chemie International Edition 60 (6), 3008-3015, 2021
152021
Primary chemical sequence ultimately determines crystal thickness in segmented all-aliphatic copolymers
YI Odarchenko, DV Anokhin, D Doblas, M Rosenthal, JJ Hernandez, ...
Macromolecules 47 (22), 7890-7899, 2014
112014
Method for preparing cell targeting conjugates, and the complexes obtained
HJ Houthoff, AAMS Van Dongen, RJ Kok, DCJ Waalboer, SJ Buwalda, ...
US Patent 10,668,162, 2020
82020
A successful search for new, efficient, and silver-free manufacturing processes for key platinum (II) intermediates applied in antibody–drug conjugate (ADC) production
E Merkul, NJ Sijbrandi, I Aydin, JA Muns, RJRW Peters, P Laarhoven, ...
Green chemistry 22 (7), 2203-2212, 2020
52020
Polymeric Micelles Employing Platinum (II) Linker for the Delivery of the Kinase Inhibitor Dactolisib
H Shi, B Lou, MJ van Steenbergen, NJ Sijbrandi, WE Hennink, RJ Kok
Particle & Particle Systems Characterization 36 (8), 1900236, 2019
32019
Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β
JA Muns, E Schooten, RDJ van Dasselaar, YE Noordman, K Adamzek, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-14, 2024
12024
Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation
HJ Houthoff, NJ Sijbrandi, JA Muns, JH Schooten, SD Pronk
US Patent App. 17/436,629, 2022
2022
Methods for preparing cell targeting conjugates and conjugates obtainable by said methods
E Merkul, NJ Sijbrandi, JA Muns, AAMS Van Dongen, PJGM Steverink, ...
US Patent App. 16/956,467, 2021
2021
Cover Picture: An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug …
E Merkul, JA Muns, NJ Sijbrandi, HJ Houthoff, B Nijmeijer, ...
Angewandte Chemie International Edition 60 (6), 2709-2709, 2021
2021
Titelbild: An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug …
E Merkul, JA Muns, NJ Sijbrandi, HJ Houthoff, B Nijmeijer, G Rheenen, ...
Angewandte Chemie 133 (6), 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20